1 Min Read
May 3 (Reuters) - Edge Therapeutics Inc:
* Edge Therapeutics reports first quarter 2017 financial results and continued operational progress
* Qtrly loss per share $0.42 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.